MeSH Browser

MeSH Heading: Foscarnet
Tree Number(s): D02.241.081.018.677.250; D02.705.429.875.500
Unique ID: D017245
RDF Unique Identifier: http://id.nlm.nih.gov/mesh/D017245
Scope Note: An antiviral agent used in the treatment of cytomegalovirus retinitis. Foscarnet also shows activity against human herpesviruses and HIV.
Entry Term(s): Foscarnet Barium (2:3) Salt; Foscarnet Calcium (2:3) Salt; Foscarnet Disodium Salt; Foscarnet Magnesium (2:3) Salt; Foscarnet Manganese (2+) (2:3) Salt; Foscarnet Sodium; Foscarnet Sodium Hexahydrate; Foscarnet Trilithium Salt; Foscarnet Tripotassium Salt; Foscarnet Trisodium Salt; Foscavir; Phosphonoformate; Phosphonoformic Acid; Trisodium Phosphonoformate
Pharm Action: Antiviral Agents
Reverse Transcriptase Inhibitors
Registry Number: 364P9RVW4X
Related Numbers: 4428-95-9; 55920-02-0; 55920-03-1; 55920-04-2; 55920-05-3; 55920-07-5; 55920-08-6; 66706-14-7; 964YS0OOG1
CAS Type 1 Name: Phosphinecarboxylic acid, dihydroxy-, oxide
Previous Indexing: Formates (1978-1980); Organophosphorus Compounds (1978-1980); Phosphonoacetic Acid (1981-1992)
Public MeSH Note: 1993; FOSCARNET was indexed under PHOSPHONOACETIC ACID 1981-1992 and under ORGANOPHOSPHORUS COMPOUNDS and FORMATES 1978-1980
History Note: 1993 (1980); FOSCARNET was SY to PHOSPHONOFORMIC ACID (NM) 1983-1992
Date Established: 1993/01/01
Date of Entry: 1992/05/19
Revision Date: 2018/06/13

Allowable Qualifiers: administration & dosage (AD)

adverse effects (AE)

agonists (AG)

analogs & derivatives (AA)

analysis (AN)

antagonists & inhibitors (AI)

blood (BL)

cerebrospinal fluid (CF)

chemical synthesis (CS)

chemistry (CH)

classification (CL)

economics (EC)

history (HI)

immunology (IM)

isolation & purification (IP)

metabolism (ME)

pharmacokinetics (PK)

pharmacology (PD)

poisoning (PO)

radiation effects (RE)

standards (ST)

supply & distribution (SD)

therapeutic use (TU)

toxicity (TO)

urine (UR)

Foscarnet MeSH Descriptor Data 2023